To systematically review randomised control trials that have evaluated the efficacy and safety of sarpogrelate hydrochloride versus placebo or other medications for peripheral arterial disease.
This is a protocol.
Sarpogrelate for peripheral arterial disease
You may also be interested in:
- Lipid-lowering for peripheral arterial disease of the lower limb
- Drugs to prevent the re-occurrence of narrowing of blood vessels in peripheral arterial disease after the blood vessels have been surgically widened
- Cilostazol for peripheral arterial disease
- Antiplatelet agents for reducing risks in patients with peripheral arterial disease and cramping pain in legs on walking
- Endoluminal stents for iliac and infrainguinal arterial disease